Ironwood cuts 120 jobs (50% of workforce) amid apraglutide submission, Shionogi's RSV drug succeeds in Phase 2, and multiple companies announce deals and layoffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback